TARA
Protara Therapeutics·NASDAQ
--
--(--)
--
--(--)
TARA fundamentals
Protara Therapeutics (TARA) released its earnings on Nov 10, 2025: revenue was 0 (YoY --), met estimates; EPS was -0.31 (YoY +38.00%), beat estimates.
Revenue / YoY
0
--
EPS / YoY
-0.31
+38.00%
Report date
Nov 10, 2025
EPS
Actual | -1.81 | -1.22 | -1.26 | -0.79 | -1.2 | -1.14 | -0.96 | -0.91 | -0.96 | -0.8 | -0.68 | -3.46 | -0.8 | -1 | -0.87 | -0.9 | -0.97 | -0.45 | -0.5 | -0.48 | -0.29 | -0.35 | -0.31 | ||||||||
Forecast | -0.41 | -0.83 | -0.625 | -0.5433 | -0.7267 | -1.0525 | -1.01 | -0.9433 | -0.9033 | -0.9367 | -0.7567 | -0.75 | -0.8767 | -0.875 | -0.98 | -0.9175 | -0.92 | -0.8 | -0.52 | -0.565 | -0.4518 | -0.385 | -0.384 | ||||||||
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -341.46% | -46.99% | -101.60% | -45.41% | -65.13% | -8.31% | +4.95% | +3.53% | -6.28% | +14.59% | +10.14% | -361.33% | +8.75% | -14.29% | +11.22% | +1.91% | -5.43% | +43.75% | +3.85% | +15.04% | +35.81% | +9.09% | +19.27% |
Revenue
Actual | -- | -- | -- | -- | -- | -- | -- | -- | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Forecast | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings Call
You can ask Aime
Did Protara Therapeutics beat or miss consensus estimates last quarter?What is Protara Therapeutics's latest dividend and current dividend yield?What were the key takeaways from Protara Therapeutics's earnings call?What factors drove the changes in Protara Therapeutics's revenue and profit?What is the market's earnings forecast for Protara Therapeutics next quarter?What is Protara Therapeutics's gross profit margin?What is the revenue and EPS growth rate for Protara Therapeutics year over year?What guidance did Protara Therapeutics's management provide for the next earnings period?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
